Moderna stock crumbled Thursday after the biotech company missed sales estimates for its two products, Spikevax and mResvia.

A new Stanford blood test detects cancer and tissue damage by analyzing rare RNA fragments in the blood. Stanford Medicine ...

Total operating loss from continuing operations increased from $6.6 million in 2023 to $6.9 million in 2024. Research and ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $20.0, a high estimate of $26.00, ...

Fusobacteria, which are part of the oral microbiome, are suspected of playing a role in cancer progression. Scientists at the ...

Cosi V, Jung J, Popella L, Ponath F, Ghosh C, Barquist L, Vogel J (2025) An antisense oligomer conjugate with unpredicted bactericidal activity against Fusobacterium nucleatum. mBio, DOI: 10.1128/mbio ...

The Boehringer Ingelheim Foundation is providing 600,000 Euros in funding for basic research into new approaches to the treatment of liver fibrosis and fatty liver hepatitis.

The Creative Biogene division IntegrateRNA launched a novel platform that enables post-translational protein modification through the use of non-canonical amino acids and engineered transfer RNA. The ...

Despite the challenges associated with studying exosomes due to their low abundance, small size, and fragility, they are ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...